Terms ending in 2027
Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,440,702 | 1,3-Oxazolidin -2-ONE Derivatives Useful as Cetp Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,781,426 | Cetp Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,592,337 | Di-Aryl Substituted Tetrazole Modulators of Metabotropic Glutamate RECEPTOR-5 In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,349,825 | Spirocyclic Compounds In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,524,842 | Compounds for the Treatment of Inflammatory Disorders In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,683,088 | Compounds for the Treatment of Inflammatory Disorders In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,772,263 | Compounds for the Treatment of Inflammatory Disorders In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,795,304 | Histone Deacetylase Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,569,521 | Benzenesulfonyl-Chromane, Thiochromane, Tetrahydronaphthalene and Related Gamma Secretase Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,664,411 | Tetrahydropyranochromene Gamma Secretase Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| 112 more term ends in 2027 · Pro | |||||
10 of 122 patents shown. Soonest term end first, then patent number.
Pro members see all 122, all of them expiring within the 18 months from Nov 17, 2026.
119 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.